...
首页> 外文期刊>Heart rhythm: the official journal of the Heart Rhythm Society >Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: A multicenter study
【24h】

Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: A multicenter study

机译:利用第二代肺静脉肺静脉分离的急性疗效,安全性和长期临床结果,患有左常见的肺静脉:多中心研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and persistent atrial fibrillation (PersAF). However, the CB2 features a maximal diameter of 28 mm, and its adaptability to anatomic variations of the pulmonary veins (PVs) might be challenging.
机译:背景技术第二代低温(CB2)的肺静脉分离(PVI)已经证明令人鼓舞的临床导致治疗阵发性(PAF)和持续的心房颤动(PERSAF)。 然而,CB2具有最大直径为28mm,其对肺静脉(PVS)的解剖变化的适应性可能是具有挑战性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号